Drug Shortage Report for ALOXI

Last updated on 2020-04-02 History
Report ID 107574
Drug Identification Number 02381729
Brand name ALOXI
Common or Proper name Aloxi
Company Name KNIGHT THERAPEUTICS INC.
Market Status DORMANT
Active Ingredient(s) PALONOSETRON
Strength(s) 0.5MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 1
ATC code A04AA
ATC description ANTIEMETICS AND ANTINAUSEANTS
Reason for shortage Other (Please describe in comments)
Anticipated start date 2020-03-02
Actual start date 2020-03-02
Estimated end date 2020-04-30
Actual end date 2020-03-27
Shortage status Resolved
Updated date 2020-04-02
Company comments Testing Method change has resulted in additional testing requirements.
Health Canada comments
Tier 3 Status No
Contact Address 3400 DE MAISONNEUVE BLVD W
MONTREAL, QUEBEC
CANADA H3Z 3B8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2020-03-02 English Compare
v2 2020-03-02 English Compare
v3 2020-03-02 French Compare
v4 2020-03-03 English Compare
v5 2020-03-24 English Compare
v6 2020-03-24 French Compare
v7 2020-04-02 English Compare
v8 2020-04-02 French Compare

Showing 1 to 8 of 8